More on PODD
Data
Financials
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $149.19 |
|
|||
| Open | $149.61 | ||||
| 52 Wk High | $45.60 | ||||
| 52 Wk Low | $23.94 | ||||
| Day High | $150.60 | ||||
| Day Low | $145.14 | ||||
| P/E | N/A | ||||
| EPS | $-1.00 | ||||
| Volume | 488,029 | ||||
- Insulet Corporation (PODD) PT Lowered to $219 at Truist Securities
- Insulet reports positive trial data for next-generation diabetes systems
- Insulet Reveals New Data Supporting Breakthrough Omnipod® 6 and Fully Closed-Loop AID Systems Designed to Improve Outcomes, Reduce Effort, and Unlock Barriers to Care
- Form 4 INSULET CORP For: Jun 03 Filed by: STONESIFER TIMOTHY C.
- Form 4 INSULET CORP For: Jun 03 Filed by: BORIO LUCIANA
- Insulet to Spotlight New Data and Innovations Demonstrating How Omnipod® Simplifies Diabetes Management and Delivers Strong Clinical Outcomes at the American Diabetes Association 86th Scientific Sess
- Form 4 INSULET CORP For: Jun 03 Filed by: WEATHERMAN ELIZABETH H
- Form 144 INSULET CORP Filed by: BORIO LUCIANA
- Insulet rolls out enhanced Omnipod 5 algorithm with Abbott sensor compatibility
- Insulet Announces U.S. Rollout of Enhanced Omnipod® 5 Algorithm and Expands Compatibility with Abbott’s FreeStyle Libre 3 Plus Sensor
Entities mentioned with PODD
- Earnings | View Related Stories »
- FDA | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- 13G | View Related Stories »
- Definitive Agreement | View Related Stories »
- JPMorgan | View Related Stories »
- Show More...
